Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111

Hafsah Nabi, Bente Glintborg, AG Loft, O Hendricks, JK Pedersen, SA Just, Rabiah Ahmed, Kamilla Danebod, H Munk, A Colic, A Linauskas, Dorte Vendelbo Jensen, J Raun, J Grydehøj, LB Christensen, Natalia Manilo, N Lomborg, S Kristensen, F Mehnert, NS KroghMerete Lund Hetland

Original languageEnglish
Article number0573
JournalArthritis and Rheumatology
Issue numberNo. S9
Pages (from-to)1161-3
Number of pages3
Publication statusPublished - 2021

Cite this